Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Share-based Compensation (2024 - 2025)

Connect Biopharma Holdings' Share-based Compensation history spans 2 years, with the latest figure at $916000.0 for Q3 2025.

  • For Q3 2025, Share-based Compensation fell 54.7% year-over-year to $916000.0; the TTM value through Sep 2025 reached $4.2 million, changed N/A, while the annual FY2024 figure was $6.7 million, 24.68% up from the prior year.
  • Share-based Compensation for Q3 2025 was $916000.0 at Connect Biopharma Holdings, down from $951000.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $2.0 million in Q3 2024 and bottomed at $916000.0 in Q3 2025.